Hybrid lipid-biopolymer nanocarrier as a strategy for GBM photodynamic therapy (PDT)
HFG Barbosa, HL Piva, FS Matsuo… - International Journal of …, 2023 - Elsevier
Glioblastoma (GBM) is the most common brain cancer characterized by aggressive and
infiltrated tumors. For this, hybrid biopolymer-lipid nanoparticles coated with biopolymers …
infiltrated tumors. For this, hybrid biopolymer-lipid nanoparticles coated with biopolymers …
[HTML][HTML] Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in …
With the understanding of microRNA (miRNA or miR) functions in tumor initiation,
progression, and metastasis, efforts are underway to develop new miRNA-based therapies …
progression, and metastasis, efforts are underway to develop new miRNA-based therapies …
Maleimide-functionalized liposomes: prolonged retention and enhanced efficacy of doxorubicin in breast cancer with low systemic toxicity
C Tang, D Yin, T Liu, R Gou, J Fu, Q Tang, Y Wang… - Molecules, 2022 - mdpi.com
Cell surface thiols can be targeted by thiol-reactive groups of various materials such as
peptides, nanoparticles, and polymers. Here, we used the maleimide group, which can …
peptides, nanoparticles, and polymers. Here, we used the maleimide group, which can …
[HTML][HTML] Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1
Y Wang, Q Chen, S Wu, X Sun, R Yin, Z Ouyang… - … Pharmaceutica Sinica B, 2023 - Elsevier
Alcoholic liver disease (ALD) results from continuous and heavy alcohol consumption. The
current treatment strategy for ALD is based on alcohol withdrawal coupled with antioxidant …
current treatment strategy for ALD is based on alcohol withdrawal coupled with antioxidant …
Breast cancer: Circular RNAs mediating efficacy in preclinical in vivo models
UH Weidle, HE Hsia, U Brinkmann - Cancer Genomics & …, 2023 - cgp.iiarjournals.org
In order to identify new targets and treatment modalities for breast cancer, we searched the
literature for circular RNAs (circRNAs) with efficacy in preclinical breast cancer-related in …
literature for circular RNAs (circRNAs) with efficacy in preclinical breast cancer-related in …
A Pioglitazone Nanoformulation Designed for Cancer-Associated Fibroblast Reprogramming and Cancer Treatment
S Theivendran, H Xian, J Qu, Y Song, B Sun… - Nano Letters, 2024 - ACS Publications
The recent focus of cancer therapeutics research revolves around modulating the
immunosuppressive tumor microenvironment (TME) to enhance efficacy. The tumor stroma …
immunosuppressive tumor microenvironment (TME) to enhance efficacy. The tumor stroma …
Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression
S You, Z Luo, N Cheng, M Wu, Y Lai, F Wang… - Drug Delivery and …, 2023 - Springer
Circular RNAs (circRNAs) are a class of highly stable and closed-loop noncoding RNA that
are involved in the occurrence and development of hepatocellular carcinoma (HCC) …
are involved in the occurrence and development of hepatocellular carcinoma (HCC) …
Current advancements in self-assembling nanocarriers-based siRNA delivery for cancer therapy
G Kandasamy, D Maity - Colloids and Surfaces B: Biointerfaces, 2023 - Elsevier
Different therapeutic practices for treating cancers have significantly evolved to compensate
and/or overcome the failures in conventional methodologies. The demonstrated potentiality …
and/or overcome the failures in conventional methodologies. The demonstrated potentiality …
Formulation and Characterization of Fe3O4@PEG Nanoparticles Loaded Sorafenib; Molecular Studies and Evaluation of Cytotoxicity in Liver Cancer Cell Lines
M Ebadi, A Rifqi Md Zain, TH Tengku Abdul Aziz… - Polymers, 2023 - mdpi.com
Iron oxide nanoparticles are one of the nanocarriers that are suitable for novel drug delivery
systems due to low toxicity, biocompatibility, loading capacity, and controlled drug delivery to …
systems due to low toxicity, biocompatibility, loading capacity, and controlled drug delivery to …
The Efficacy and Safety of Polyethylene Glycol Cholesterol-and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small …
Z Zeng, X Zeng, X Li, Y Feng, Y Kan, X Liu, Y Zeng - Pharmaceutics, 2024 - mdpi.com
The aim of this study was to explore the efficacy and safety of TGFβ1 siRNA lipid
nanoparticles (LNPs) modified with different PEG derivatives (PEG5000 cholesterol …
nanoparticles (LNPs) modified with different PEG derivatives (PEG5000 cholesterol …